Related Experiment Video
Updated: Oct 13, 2025

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
Sordarin- An anti-fungal antibiotic with a unique modus operandi
Yutian Shao1,2, Eliza Molestak2, Weike Su1,3,4
1Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, China.
Abstract:
Fungal infections cause serious problems in many aspects of human life, in particular infections in immunocompromised patients present serious problems. Current anti-fungal antibiotics target various metabolic pathways, predominantly the cell wall or cellular membrane metabolism. Numerous compounds are available to combat fungal infections, but their efficacy is far from satisfactory and some of them display high toxicity. The emerging antibiotic resistance represents a serious issue as well. Hence, there is a considerable need for new anti-fungal compounds with lower toxicity and higher effectiveness. One of the unique anti-fungal antibiotics is sordarin, the only known compound that acts on the fungal translational machinery per se. Sordarin inhibits protein synthesis at the elongation step of the translational cycle, acting on eukaryotic translation elongation factor 2. In this review, we deliver a robust scientific platform promoting the development of anti-fungal compounds, in particular focusing on the molecular action of sordarin.
Insights
New antifungal compounds are needed due to resistance and toxicity issues. Sordarin offers a unique approach by targeting fungal protein synthesis, specifically inhibiting eukaryotic translation elongation factor 2.
Area of Science:
- Mycology
- Pharmacology
- Molecular Biology
Background:
- Fungal infections pose significant health risks, especially in immunocompromised individuals.
- Existing antifungal drugs have limitations including unsatisfactory efficacy, toxicity, and emerging resistance.
- There is a critical need for novel antifungal agents with improved safety and effectiveness.
Purpose of the Study:
- To review the molecular mechanisms of antifungal compounds.
- To highlight sordarin as a unique antifungal agent targeting fungal protein synthesis.
- To provide a scientific platform for developing new antifungal drugs.
Main Methods:
- Literature review of current antifungal therapies.
- Analysis of the molecular action of sordarin.
- Focus on sordarin's inhibition of protein synthesis at the elongation step.
Main Results:
- Sordarin uniquely targets the fungal translational machinery.
- It specifically inhibits eukaryotic translation elongation factor 2 (eEF2).
- This action disrupts protein synthesis in fungi.
Conclusions:
- Sordarin represents a promising novel antifungal agent.
- Its distinct mechanism of action may overcome existing resistance issues.
- Further research into sordarin and similar compounds is warranted for developing effective antifungals.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Gene Regulation in Microbial Communities: Quorum Sensing
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Fungal Phylum Basidiomycota
Fungal Phylum Microsporidia
Drugs that Destabilize Microtubules

